Kulkarni, Prakash
City Of Hope National Medical Center
3 papers on CoChatORCID 0000-0001-6736-4333
Most cited papers
- Verified
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
Mohanty, A., Nam, A., Srivastava, S., Jones, J., Lomenick, B., Singhal, S. S., Guo, L., Cho, H., Li, A., Behal, A., et al. (2023) · Science Advances
Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling
Cited by 79
- Verified
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance
Sattler, M., Mohanty, A., Kulkarni, P., & Salgia, R. (2023) · Trends in Cancer
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 54
- Verified
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Zhao, D., Li, H., Mambetsariev, I., Mirzapoiazova, T., Chen, C., Fricke, J., Kulkarni, P., Villaflor, V., Arvanitis, L., Hamilton, S., et al. (2022) · Cancers
Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free